Skip to main content
HWAIL PHARM. CO., LTD logo

HWAIL PHARM. CO., LTD — Investor Relations & Filings

Ticker · 061250 ISIN · KR7061250007 KO Manufacturing
Open in API
Filings indexed 273 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 061250

About HWAIL PHARM. CO., LTD

http://www.hwail.com/

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” and covers the first quarter of the 46th fiscal term (2026.01.01–2026.03.31). It contains substantive financial data, detailed tables of capital changes, share counts, business overview, and operational metrics typical of a quarterly report. Hence, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
주권매매거래정지해제 (액면병합 주권 변경상장)
Delisting Announcement Classification · 90% confidence The document is a short notice about the lifting of a trading suspension for a stock (화일약품(주)) due to a stock consolidation and re-listing. It references specific market regulations and provides the date when trading will resume. The content is regulatory in nature, brief, and does not contain financial statements or detailed reports. It is an official announcement related to stock trading status, which fits the category of a Delisting Announcement or similar. However, since it is about lifting a suspension rather than delisting, and given the options, the best fit is 'DLST' (Delisting Announcement) as it covers official notices about stock status changes on exchanges. Confidence is high due to clear regulatory references and the nature of the notice.
2026-04-30 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's classification or department within an exchange or regulatory framework, specifically a change from '중견기업부' (Mid-sized Enterprise Division) to '우량기업부' (Excellent Enterprise Division). It does not contain financial data, management changes, or detailed reports. This type of announcement is a regulatory update about the company's status or classification rather than a financial report or management change. Therefore, it fits best under Regulatory Filings (RNS). The document is very short (232 characters), confirming it is an announcement rather than a full report.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 94% confidence The document is a Korean regulatory form titled “임원ㆍ주요주주 특정증권등 소유상황보고서” which literally reports the ownership and changes in specific securities by a director or major shareholder. It lists the director’s name, share counts before and after, percentages, change reasons, and transaction details. This matches the insider transaction/Director’s Dealing category. Therefore, it should be classified as DIRS.
2026-04-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a regulatory filing in Korean titled "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on ownership status of certain securities by officers and major shareholders). It details insider share ownership changes, shares held, percentages, acquisition/disposition dates, and is addressed to the Securities and Futures Commission and Korea Exchange. This matches the definition of a Director's Dealing report (personal share transactions by company directors/executives and major shareholders).
2026-04-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a statutory ‘주식등의 대량보유상황보고서’ (Large Shareholding Status Report) filed under the Capital Markets Act Article 147, detailing changes in major shareholdings, thresholds, percentages, and related disclosures. This matches our “Major Shareholding Notification” category (MRQ).
2026-04-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.